Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome Intervention: Drug: Sirolimus Sponsors: Anne Comi, MD; Children's Hospital Medical Center, Cincinnati; Pfizer; National Institutes of Health (NIH); Faneca 66 Foundation; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials